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The synthesis, structure, electrochemistry, and biological studies of Co(II), Ni(II), Cu(II), and Zn(II) complexes of thiocarbo-
hydrazone ligand are described. The ligand is synthesized starting from thiocarbohydrazide and isatin. It is evident from the IR
data that in all the complexes, only one part of the ligand is coordinated to the metal ion resulting mononuclear complexes. The
ligand coordinates essentially through the carbonyl oxygen of the isatin fragment, the nitrogen atom of the azomethine group, and
sulfur atom after deprotonation to give ﬁve membered rings. 1H NMR spectrum of the ligand shows only one set of signals for
the aromatic protons, while the NH of isatin and NH of hydrazone give rise to two diﬀerent singlets in the 11–14 ppm range. The
formulations, [Cu(L)Cl]·2H2O, [Cu(L)(CH3COO)]·2H2O, [Ni(L)Cl], [Ni(L)(CH3COO)], [Co(L2)], and [Zn(L2)]·2H2Oa r ei n
accordance with elemental analyses, physical, and spectroscopic measurements. The complexes are soluble in organic solvents.
Molar conductance values in DMF indicate the nonelectrolytic nature of the complexes. Copper complex displays quasireversible
cyclic voltametric responses with Ep near −0.659 v and 0.504 v Vs Ag/AgCl at the scan rate of 0.1 V/s. Copper(II) complexes show
a single line EPR signals. For the observed magnetic moment and electronic spectral data possible explanation has been discussed.
From all the available data, the probable structures for the complexes have been proposed. The compounds synthesized in present
study have shown promising cytotoxic activity when screened using the in vitro method and at the same time were shown to have
good activity when tested using the Ehrlich ascites carcinoma (EAC) model. The antimicrobial screening showed that the cobalt
complex possesses enhanced antimicrobial activity towards fungi.
Copyright © 2008 M. P. Sathisha et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1. INTRODUCTION
Although ligands having oxygen and nitrogen as donor
atoms are by far the most extensively studied, interest in sul-
fur donor chelating agents has grown over the years and the
numberofchemicalstudies inthisareahasincreasedconsid-
erably [1]. Interest in complexes of these ligand systems now
covers several areas, ranging from general considerations of
the eﬀect of sulfur and electron delocalization in transition
metal complexes to potential biological activity and practical
application [2–4].
The aim of the present work is to synthesize new thio-
carbohydrazone ligand, and to study its coordination be-
havior with Co(II), Ni(II), Cu(II), and Zn(II) ions. N, N
 -
Thiocarbohydrazide condenses easily with two molecules of
carbonyl compounds viz., isatin, on the N1H2 and N4H2 hy-
drazine amino groups to produce the desired ligand shown
in Figure 1. The tautomerism in this ligand and also the well-
known tendency of oxygen and sulfur donors to act as bridg-
ing sites [5, 6] allows various structural possibilities for the
corresponding metal complexes.
A considerable number of metal complexes are now
known to possess antitumor activity [7]. There are reports
that sulphur-containing ligands [8] and platinum com-
plexes of sulphur-containing amino acids were found to have
inhibitory action against tumors [9]. However, since the2 Metal-Based Drugs
N
H
O
N
HN
S
NH
N
O N
H
Figure 1: Representative structure of the ligand.
class of sulphur-containing compounds such as thiosemi-
carbazones, an structural analogue of the thiocarbohydra-
zone, have been reported to have anticancer activity owing
to the speciﬁc and unique properties of their metal chelate
[10], it is suggested that the present compounds, being sim-
ilar in structure and character, may be acting by virtue of
theirchelatingpropertiesatthecellularleveltherebyexerting
theiranticanceractivity.Hence,itwasconsideredworthwhile
to subject the presently studied complexes for evaluation of
their anticancer activity.
The antimicrobial properties of metals have been recog-
nized for centuries and have represented some of the most
fundamental breakthroughs in medicinal history [11]. Many
studies stressed the role of metal ions in important biolog-
ical processes, whereas the inorganic pharmacology started
to be an important ﬁeld with more than 25 inorganic com-
pounds, being used in therapy as antibacterial, antiviral, and
anticancerdrugs[12,13].Kirschneretal.[14]ha vesuggested
that the transfer of the metal ion from the ligand to the
cancer-associated viruses was an important mechanism for
designing new anticancer therapies. The inverse process, that
is, coordinating a metal ion from an important biomolecule,
such as, for instance, a zinc ﬁnger protein, has recently been
used to design novel antiviral therapies, targeted against hu-
man immunodeﬁciency (HIV) and human papilloma virus
(HPV) infections [15]. We have already drawn attention to
the strong relationship between metals or their complexes
[16–18], and antibacterial [19], antitumour [20], and anti-
cancer [21] activities. A number of in vivo studies have indi-
cated [22] that biologically active compounds become more
bacteriostatic and carcinostatic upon chelation.
2. EXPERIMENTAL
2.1. Materials,analyticalmethods,and
physicalmeasurements
All chemicals used were of reagent grade. Solvents were
distilled prior to use. The metal content of the complexes
were estimated after decomposition with mixture of HCl
and HClO4 by gravimetric method (copper and nickel) and
EDTA titration method (cobalt and zinc). Magnetic suscep-
tibility of complexes were measured at room temperature on
a Faraday balance using Hg[Co(SCN)4] as a calibrant. Elec-
tronic spectra were recorded using VARIAN CARY 50 Bio
UV-Visible spectrophotometer in DMSO. The IR spectra of
ligand and its complexes were recorded as KBr pellets in the
region 4000–400 cm−1 on Nicolet 170 SX FT-IR spectrome-
ter. The 1H-NMR spectra of ligand and its zinc (II) complex
were recorded in DMSO-d6 on Bruker 300MHz spectrome-
ter using TMS as an internal standard. The cyclic voltamme-
try experiments were carried out with a three-electrode ap-
paratus using a CHI1110A electrochemical analyzer (USA).
The EPR spectra of copper (II) complexes were recorded at
room temperature on Varian E-4 X-band spectrometer using
TCNE as g-marker. Conductivity measurements were made
on 10−3 M solutions of complexes in DMSO using ELICO-
CM82 conductivity bridge provided with a cell having cell
constant 0.51.
2.2. SynthesisofN,N
 -Thiocarbohydrazonebis(isatin)
A solution of isatin 5.8g (0.04mol) in ethanol (30ml) was
added drop wise to a reﬂuxing solution of thiocarbohy-
drazide 2.1g (0.02mol) in the same solvent (40ml). Few
drops of glacial acetic acid were added to the reaction mix-
ture and was reﬂuxed for 2hours. At the end of the reac-
tion, monitored by TLC (n-hexane/ethyl acetate 2 : 3), a
yellow-orange powder was ﬁltered and washed with warm
ethanol and then with diethyl ether. Yield 75%. M.P. 284◦C
(Scheme 1).
The thiocarbohydrazide was prepared as described in the
literature [23].
2.3. Synthesisofmetal(II)chlorideand
acetatecomplexes
In a representative preparation, the complex was prepared by
the addition of ethanolic solution of metal (II) chloride or
aqueous ethanolic solution of metal (II) acetates (0.003mol)
with constant stirring to the corresponding amount of the
ligand (0.003mol) in the same solvent. The mixture was
heated to reﬂux for 1 hour. The product was ﬁltered oﬀ,
washed several times with ethanol, and dried in vacuum over
P2O5 (Scheme 2).
2.4. Brineshrimplethalitybioassay[24]
The brine shrimp lethality test was used to predict the pres-
ence of cytotoxic activity. The brine shrimp (Artemia salina)
eggs were procured from www.brineshrimp.com. The brine
shrimp eggs were hatched in artiﬁcial sea water at room tem-
perature under constant aeration for 48hours. After hatch-
ing,10larvaewereplacedinavialcontaining5mlofartiﬁcial
sea water. A drop of dry yeast suspension (3mg in 5ml sea
water) was added to each vial as food for shrimps. Test com-
pounds in diﬀerent concentrations (10, 100, and 1000ppm)
were added to the vials before making up the ﬁnal volume
t o5m lw i t hs e aw a t e r .T h ec o n t r o lg r o u ph a ds h r i m pi na r -
tiﬁcial sea water. The vials were maintained under illumina-
tion with 40W electric bulb. The experiments were done in
triplicate and mean of three readings was taken as ﬁnal re-
sult. After 24 hours, the survivors were counted using a 3X
magnifying glass, and the percent deaths and LC50 (Lethal
concentrationforhalfthepopulation) valueswearcalculated
by using Finney computer program.M. P. Sathisha et al. 3
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Scheme 2: Representative synthesis of copper chloride complex.
2.5. Celllines
Cancer cell lines viz. Ehrlich ascitic carcinoma (EAC), to in-
duce cancer in animal model (mice) were obtained from
(AmalaCancerResearchCenter,AmalaNagar,Kerala,India.)
The cells were maintained as ascites tumor in Swiss Albino
mice by intraperitoneal inoculation of 1 ×106 viable cells.
2.6. Animals
Six-to-eight week old female Swiss Albino mice (25 ± 5g
body weight) were selected from (Central Animal Facility,
Manipal Academy of Higher Education, Manipal, Karnataka,
India.) The animals were acclimatized to the experimental
roomhavingtemperature23±2◦C,controlledhumiditycon-
ditions, and 12 : 12 hour light and dark cycle. The mice
were housed in sterile polypropylene cages containing sterile
paddy husk as bedding material with a maximum of 4 ani-
mals in each cage. The mice were fed on autoclaved standard
mice food pellets (Hindustan Lever) and had access to water
ad libitum. The animal experiments were performed accord-
ing to the rules and regulations of the Institutional Animal
Ethics Committee (IAEC).
2.7. Preparationoftestsolutionofcompounds
Thecompounds(dose50mg/kg),suspendedin4%gumaca-
cia (gummy exudates from the bark of Acacia senegal, an in-
active substance, which forms a mucilage with water) were
administrated intraperitoneally, daily once for 5 days from
day 10 posttumor inoculation in a volume of 0.1ml/10g
mouse.Thedoseofcisplatinselectedwas3.5mg/kg.Thiswas
calculated from the human dose using an appropriate con-
version factor [25].
3. ANTITUMOR ACTIVITY
3.1. Determinationofcytotoxicityofcompoundsto
EACcells(invitrostudies)Tryphanblueexclusion
method(cellviabilitytest)
Invitroshort-termcytotoxicactivityofdrugwasdetermined
using EAC cells. The EAC cells that were collected from the
animal peritoneum by aspiration were washed repeatedly
with phosphate buﬀered saline (PBS) to free it from blood.
The viability of the cells was checked in a haemocytometer.
The cells (1 × 106 in 0.1ml PBS) were incubated in clean
sterile tubes with the test compounds (0.01ml, 1–50μg/ml
in dimethyl sulfoxide (DMSO)) for 3 hours at 37◦C, keeping
the ﬁnal volume at 0.9ml. The volume of DMSO was pegged
below0.1%ofthetotalvolume.Thecontroltubehad10μlof
solvent.Theﬁnalvolumewasmadeupto0.9mlwithPBS.To
eachtube100μlofTryphanbluesolutionwasadded.Thelive
(without stain) and dead (with blue stain) cells were counted
using haemocytometer and percent cell death was calculated
using the formula:
% Cytotoxicity = 100 ×

Tdead −Cdead

/Ttot,( 1 )
where Tdead is the number of dead cells in the treated group,
Cdead isthatin thecontrolgroup, andTtot is thetotalnumber
of dead and live cells in the test compound treated group.
Cisplatin was used as the standard [26].
3.2. InductionofEhrlichAscitesCarcinoma[27]
Antitumor activity of the compounds was determined us-
ing Ehrlich ascites carcinoma (EAC) tumor model in mice.
Female Swiss Albino mice were divided into groups of 12
a n i m a l se a c h .( ( a )N o r m a lm i c ef o rh e m a t o l o g i c a ls t u d i e s ,
(b) Tumor-bearing mice, (c) Tumor-bearing mice treated
with one dose of cisplatin, (d) Tumor-bearing mice groups4 Metal-Based Drugs
treated with compounds for 5 days.) The ascitic carcinoma-
bearing mice (donor) were used for the study, 15 days af-
ter tumor transplantation. The ascitic ﬂuid was drawn us-
ing an 18-gauge needle into sterile syringe. A small amount
was tested for microbial contamination. Tumor viability was
determined by Tryphan blue exclusion test and cells were
countedusinghaemocytometer.Theasciticﬂuidwassuitably
dilutedinnormalsalinetogetaconcentrationof106 cells/ml
of tumor cell suspension. This was injected intraperitoneally
to obtain ascitic tumor. The mice were weighed on the day
of tumor inoculation and then once in three days thereafter.
Treatmentwasstartedonthetenthdayoftumorinoculation.
Cisplatin (one dose) was injected on tenth day intraperi-
toneally. The compounds were administered from tenth day
for 5 days intraperitoneally. After the administration of last
dose followed by 18-hour fasting, six mice from each group
were sacriﬁced for the study of antitumor activity and hema-
tological parameters. The remaining animals in each of the
groups were kept to check the mean survival time (MST)
of the tumor-bearing hosts. Antitumor eﬀects of compounds
were assessed by observation of following parameters.
3.3. Percentageincreaseinweight
ascomparedtoday-0weight
Upon weighing the animal on the day of inoculation and
after once in three days in the postinoculation period, the
percentage increase in weight was calculated using the for-
mula: % Increase in weight = [(animal weight on respective
day/animal weight on day-0) −1] ×100 [28].
3.4. Mediansurvivaltimeandincrease
inlifespan[%ILS]
Total number of days an animal survived from the day of tu-
mor inoculation was counted. Subsequently, the median and
mean survival time were calculated. The percentage increase
inlifespan(%ILS)wascalculatedusingtheformula:ILS(%)
= [(mean survival time of treated group/mean survival time
of control group) −1]×100 [26].
3.5. Hematologicalparameters[29]
In order to detect the inﬂuence of compounds on the hema-
tological status of EAC-bearing mice, comparison was made
amongst groups of mice for each compound on the four-
teenth day after transplantation. Blood was drawn from each
mouse from retro orbital under ether anesthesia and the
white blood cell (WBC) total count, diﬀerential leukocyte
counts, red blood cell (RBC) total count, and hemoglobin
content parameters were evaluated.
3.6. Statisticalanalysis
Results were analyzed by one-way ANOVA by Scheﬀe’s post-
hoc test using SPSS computer package.
4. EVALUATION OF ANTIBACTERIAL AND
ANTIFUNGAL ACTIVITIES
4.1. Antibacterialactivity
Antibacterial activity of test compounds was assessed against
Bacillus cirroﬂgellosus by cup-plate method [30].
4.1.1. Materials
(1) Nutrient agar.
(2) Sterilized petridishes and pipettes.
(3) 20–24-hour old subcultures in nutrient agar medium.
(4) Sterilized test tubes containing solution of the test
compounds in desired concentration.
4.1.2. Preparationofinoculationmedium
The deﬁnite volumes of peptone (0.5%), yeast extract
(0.15%), beef extract (0.15%), sodium chloride (0.35%),
dipotassium phosphate (0.36%), and potassium dihydrogen
phosphate (0.13%) were dissolved in distilled water and the
pH was adjusted to 7.2. This solution was sterilized by auto-
claving at 15 p.s.i. for 20 minutes.
4.1.3. Preparationofsubcultures
One day prior to these tests, inoculation of above bacterial
cultures was made in the inoculation medium as described
above and incubated at 37◦C for 18–24 hours.
4.1.4. Preparationofbase-layermedium
Base-layer medium was prepared by dissolving deﬁnite vol-
umes of peptone (0.6%), yeast extract (0.3%), beef extract
(0.13%), and agar (2.5%) in distilled water. The pH of this
medium was also adjusted to 7.2 and sterilized by autoclav-
ing at 15 p.s.i. for 20 minutes.
4.1.5. Preparationoftestcompounds
Each test compounds (5mg) was dissolved in dimethylfor-
mamide (5ml) to give a solution of 1000μg/ml. Out of this
0.1ml. of solution was used for antimicrobial testing.
4.1.6. Testingmethod
Base-layer was obtained by pouring about 10–15ml of base-
layer medium into each sterilized petridishes and were al-
lowed to attain room temperature. This solid layer after at-
taining room temperature is called base-layer. Over-night
grown sub-cultures of bacteria were mixed with seed layer
medium and immediately poured into petridishes contain-
ing the base-layer and then allowed to attain room tempera-
ture.
Thecupsweremadebyscooping outnutrientagarwitha
sterile cork borer. To these cups, solutions of test compounds
(0.1ml) were added using sterile pipettes and these plates
were subsequently incubated at 37◦C for 36 hours. The zoneM. P. Sathisha et al. 5
of inhibitions, if any, was measured in mm for the particu-
lar compound. Norﬂoxacin was used as positive-control and
solvent-control was also used to know the activity of the sol-
vent. The results of antibacterial testing are summarized in
Table 8.
4.2. Antifungalactivity
Fungicidal activity of test compounds was assessed against
Aspergillus niger and Candida albicans by cup-plate method.
4.2.1. Materials
(1) Nutrient agar.
(2) Sterilized Petri dishes and pipettes.
(3) 16–18 hoursoldsub-culturesin nutrientagarmedium
supplemented with 1% glucose.
(4) Sterilized test tubes containing solutions of the com-
pounds in desired concentration.
4.2.2. Preparationofinoculationmedium
Inoculation medium was prepared by dissolving deﬁnite vol-
umes of peptone (1.0%), yeast extract (0.6%), sodium chlo-
ride (0.5%), potassium dihydrogen phosphate (0.3%), and
glucose (1.0%) in distilled water. The pH of the medium was
adjusted to 6.0 and sterilized at 15 p.s.i. for 20 minutes.
4.2.3. Preparationofsub-cultures
One day before testing, inoculation of fungi, were made in
the inoculation medium and incubated at 37◦C for 18–24
hours.
4.2.4. Preparationofbase-layermedium
The deﬁnite volumes of peptone (4.0%), yeast extract
(0.6%), sodium chloride (0.5%), potassium dihydrogen
phosphate(0.3%),glucose(1.0%),andagar(2.5%)weredis-
solved in distilled water. The pH of the medium was adjusted
to 6.0 and sterilized by autoclaving at 15 p.s.i. for 20 minutes.
4.2.5. Preparationofseedlayermedium
The deﬁnite volumes of peptone (4.0%), yeast extract
(0.6%), sodium Chloride (0.5%), potassium dihydrogen
phosphate (0.3%), glucose (1.0%) and agar (2.5%) were dis-
solved in distilled water. The pH of medium was adjusted to
6.0 and was sterilized separately by autoclaving at 15 p.s.i. for
20 minutes.
4.2.6. Testingmethod
The method of testing for antifungal activity is the same as
that adopted for assessing antibacterial activity. Grisofulvin
was used as a positive control and solvent content was also
used to know the activity of the solvent. The fungicidal re-
sults are summarized in Table 8.
5. RESULT AND DISCUSSION
The ligand was synthesized by acid catalysedcondensation of
thiocarbohydrazidewiththeisatininethanol(Scheme1);the
condensation proceeds, as usual, selectively on the carbonyl
in position 3 in the isatin ring. The ligand is characterized by
means of IR, 1H NMR spectroscopy, and elemental analysis.
Inthe 1HNMRspectrumoftheligandthereisonlyonesetof
signals for the aromatic protons, while the NH of isatin and
NH of hydrazone give rise to two diﬀerent singlets in the 11–
14ppm range. The presence of the NH groups is conﬁrmed
intheIRspectrabyabroadpeakaround3200cm−1;theC=O
groups absorb near 1690cm−1.
The reactions between the metal(II) chlorides/acetates
andtheligand(1:1)leadtoformationofcomplexes,(Scheme
1). The growth of single crystals of these complexes for X-
ray studies is very diﬃcult owing to their amorphous na-
ture and we were unsuccessful in our attempts to do so.
The elemental analyses of these complexes reveal 1:1 ligands
to metal stoichiometry in case of Cu(II) and Ni(II). Cop-
per forms the complexes of the type [Cu(L)Cl]·2H2Ow i t h
Cu(II) chloride and [Cu(L)OAc]·2H2O in case of Cu(II)
acetate. Nickel forms [Ni(L)Cl] type complex with Ni(II)
chloride and [Ni(L)OAc] with acetate. Both cobalt and zinc
chloride and acetates form the same complexes with the
2 : 1 ligand to metal stoichiometry, with general formula,
[M(L2)]. The complexes are found to be soluble in dimethyl-
formamide, dimethylsulphoxide, and acetonitrile but insol-
uble in common organic solvents such as ethanol, methanol,
benzene, acetone, and so forth. The composition and coor-
dination geometry of these complexes has been established
on the following experimental observations. The molar con-
ductance values in dimethylsulphoxide fall in the expected
range (10–32 cm2Ω−1mol−1)o fn o n e l e c t r o l y t e s[ 31]. The
complexes were analyzed for metal, nitrogen, carbon, hydro-
gen and chloride. The analytical, conductivity, and magnetic
moment data of the complexes are summarized in Table 1.
5.1. Infraredspectralstudies
TheIRspectraldataoftheligandN,N
 -bis(isatin)thiocarbo-
hydrazoneshowsasharpabsorptionbandaround3200cm−1
attributed to the presence of NH group and a very strong
bandnear1690cm−1 assignedto(C=O)stretchingvibration.
The band at 1619cm−1 is assigned to the azomethine (C=N)
stretching. The Ir spectral assignment of metal complexes
was aided by comparison with the vibration frequencies of
the free ligand. The broad band that appears in the range
of 3160–3210cm−1 is assigned to the stretching vibration of
ring (N−H). There is only one band in the v(C=O) region
and it does not diﬀer signiﬁcantly from the band in the lig-
and; suggesting that the carbonyl groups are weakly involved
in the coordination. Although there is coordination of nitro-
gen atom of the azomethine group to the central metal atom,
we could not appreciably conclude from the Ir data, because
of remaining uncoordinated azomethine group that absorbs
at a just lower frequency near 1614-1615cm−1 as compared
to their ligand [32]. The band corresponding to the stretch-
ing vibration of the C=S group appears at 1200–1194cm−16 Metal-Based Drugs
Table 1: Elemental analysis, molar conductance, and magnetic moment measurements.
Compounds F o u n d( C a l c . )% M o l a rc o n d u c t a n c e Magnetic moment BM
CHN M C I λm(cm−1Ω
−1mol−1)
Ligand 55.8(56.1) 2.8(3.2) 23.0(23.1) — — — —
[Co(L2)] 50.9(51.1) 2.8(2.2) 21.4(20.7) 7.2(7.5) — 2.1 4.98
[Ni(L)Cl] 43.5(44.7) 2.0(2.4) 17.9(18.4) 12.2(12.8) 7.3(7.7) 3.5 3.55
[Ni(L)OAc] 40.3(41.8) 2.3(2.8) 15.7(16.2) 10.9(11.4) — 2.6 2.92
[Cu(L)Cl]·2H2O 39.6(40.8) 2.3(2.8) 16.1(16.8) 11.9(12.7) 6.7(7.1) 2.2 1.91
[Cu(L)OAc]·2H2O 43.1(43.6) 2.9(3.4) 15.9(16.1) 11.8(12.2) — 2.8 1.89
[Zn(L2)]·2H2O 46.8(47.2) 1.9(2.5) 18.6(19.4) 7.1(7.5) — 0.7 —
in the ligand [33]. The absence of this band in the Ir spectra
of the metal complexes can be explained by the tautomerism
of the C=S group with one of the imino groups to form the
C−SH and the coordination of sulphur after deprotonation.
The band that appears in the range of 690–750cm−1 is thus
assigned to the ν (C−S) in the Ir spectra of the metal com-
plexes. The Ir spectra of the complexes derived from cop-
per and nickel acetate, show an absorption bands in the re-
gion 1665–1650cm−1 which is assigned to ν8 (C−O) an-
tisymmtric stretching of acetate group and another in the
region 1297–1258cm−1 and which can be assigned to ν3
(C−O) symmetric stretching vibration of acetate. Diﬀerence
ν8 − ν3 which is around 407–493cm−1 indicates the uniden-
tate coordination of the acetate group [34]. The complexes
show a broad band around 3400cm−1, which is assigned to
the ν(H2O) absorption. The ν(M−N) and ν(M−O) stretch-
ing vibrations are observed at about 490 and 455cm−1,r e -
spectively, in the spectra of the complexes [35].
5.2. 1HNMRspectralstudies
The 1H NMR spectrum of the ligand shows only one set
of signals for the aromatic protons around 6.93–7.60ppm,
while the NH of isatin and NH of hydrazone give rise to two
diﬀerent singlets in the 11–14ppm range.
The 1H NMR spectrum of the Zn(II) complex is less
informative, the presence of the hydrazonic proton is con-
ﬁrmed by a peak at about 13ppm, which is slightly shifted to
down ﬁeld after complexation. Peak due to ring NH and re-
mainingsignalsoftheligandremainsubstantiallyunchanged
upon complexation.
5.3. Electronicspectralstudies
Electronic spectral data of the ligand and their transition
metal complexes were recorded in DMF solutions. In the
electronic spectrum of the ligand, three prominent absorp-
tion bands at 266, 382, and 670nm were characterized. The
band at 266nm corresponds to the π→π∗ transition of the
C=Sg r o u p[ 36]. The band at 382nm corresponds to the
transition of azomethine group and the band at 670nm cor-
responds to the n→π∗ transition from the amide oxygen of
the isatin moiety to the azomethine group [37].
In case of complexes, the bands appeared in the almost
same position as they were appeared in ligand. Followed by
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Figure 2: Short-term in vitro cytotoxicity of compounds towards
EAC cells.
these, the bands displayed at 485, 485 and 495nm in case of
Cu(II), Ni(II) and Co(II) complexes respectively are assigned
to ligand to metal charge transfer transitions (LMCT). Apart
from these, the bands around 899, 780nm in case of Cu(II)
and Ni(II) complexes were assigned as d-d transition bands.
5.4. Cyclicvoltametricstudies
The electrochemical behavior of copper(II) complex has
been investigated in DMSO containing 0.1M tetraethyl am-
monium chloride supporting electrolyte, using glassy car-
bon working electrode and Ag/AgCl, Pt electrodes as ref-
erence and counter electrodes, respectively. The complex
involves single redox step corresponding to Cu(II)→Cu(I),
quasireversible electrode process at Epc =− 0.659V and theM. P. Sathisha et al. 7
Table 2: Brine shrimp bioassay results of compounds.
SL. no Compound Percentage deaths at 24 hr LC50 mg/ml
5 mg/ml 10 mg/ml 20 mg/ml
1 [Cu(L)Cl]·2H2O 40 72 100 6.17
2 [Cu(L)OAc]·2H2O 27.27 66.66 100 7.26
3 Ligand 9.1 25 90 11.83
Table 3: Short-term in vitro cytotoxicity of compounds towards EAC cells.
Compounds Percentage cell-death at diﬀerent concentrations after 3 hours LC50μg/mL
1μg/mL 5μg/mL 10μg/mL 25μg/mL 50μg/mL
Cisplatin 20 32 44 88 98 6.6377
[Cu(L)Cl]·2H2O 19 37 46 67 79 11.1475
[Cu(L)OAc]·2H2O 16 31 43 65 82 10.9732
Ligand 12 28 40 56 64 19.1815
Table 4: Eﬀect of drugs on body weight changes in tumor-induced mice.
Group Dose (mg/Kg) i.p. % increase in weight as compared to Day-0 (mean ± SE)
Day-3 Day-6 Day-9 Day-12 Day-15
Control — 4.46 ±1.98 7.04 ±2.19 16.13 ±1.75 17.15 ±1.89 19.15 ±2.22
Cisplatin 3.5 4.51 ±1.15 12.04 ±1.38 19.16 ±1.34 9.91 ±2.12a 1.32 ±4.23a
[Cu(L)Cl]·2H2O5 05 .45 ±1.25 16.27 ±3.29 22.13 ±5.76 15.35 ±1.88 4.56 ±2.56a
[Cu(L)OAc]·2H2O5 0 5 .55 ±1.83 14.19 ±2.37 21.09 ±2.42 15.24 ±2.65 6.36 ±2.55a
Ligand 50 4.88 ±2.02 14.33 ±4.37 24.69 ±4.99 16.54 ±2.35 7.76 ±3.43a
aP<. 05 versus Control.
associated anodic peak at Epa = 0.504V [38] suggesting the
tetrahedral environment of the copper ion.
5.5. Magneticmeasurementstudies
The magnetic moments of the complexes were recorded at
roomtemperatureandtheobservedmagneticmomentvalue
for the Co(II) complex is 4.98 BM, which is in the range of
4.4 to 5.5 BM observed for the octahedral Co(II) complexes.
The Ni(II) complexes derived from chloride and acetate
salts exhibit the magnetic moment values 3.55 and 2.92 BM
suggesting tetrahedral environment around metal ion. The
value of 1.91 BM for Cu(II) chloride and 1.89 BM for Cu(II)
acetate complex suggests the four coordinated tetrahedral
complexes, which further supported by their electronic spec-
tral data and CV studies.
5.6. ESRspectralstudies
X-band ESR spectra of the polycrystalline Cu(II) complex
were recorded at room temperature. The ESR spectra of the
mononuclear copper chloride and acetate complexes show a
giso value in the range of 2.066 and 2.092 respectively.
5.7. AntitumoractivityofcomplexesagainstEhrlich
ascitescarcinomainSwissAlbinomice
5.7.1. Brineshrimplethalitybioassay
The Brine shrimp lethality bioassay has been chosen to assess
the in vitro cytotoxic eﬀects of the compounds, as it is an in-
expensive, reliable, and quick method for the purpose [24].
All the tested compounds showed considerable cytotoxic ac-
tivity in the brine shrimp lethality bioassay. LC50 concentra-
tions for the compounds are tabulated in Table 2.
5.7.2. Tryphanblueexclusionmethod(cellviabilitytest)
The compounds were tested using the short-term in vitro cy-
totoxicity towards EAC cells as a preliminary screening tech-
nique of Tryphan blue exclusion method (cell viability test)
for their cytotoxic potential [26]. This is one of the meth-
ods to assess cytotoxicity of anticancer compounds. This test
is based on the principle that living cell membrane has the
ability to prevent the entry of dye. Hence, they remain un-
stainedandcanbeeasilydistinguishedfromdeadcells,which
take the dye. The percentage of viable cells was determined.
Results of the short-term in vitro cytotoxicity of the com-
poundsareshowninTable 3.Thesepreliminaryexperiments8 Metal-Based Drugs
Table 5: Comparative eﬀects of treatments versus cisplatin on reduction of body weights in tumor-induced mice.
Group Dose (mg/kg) i.p. % Decrease in weight as compared to respective control (Mean ± SE)
Day 12 (Mean ± SE) Day 15 (Mean ± SE)
Cisplatin 3.5 42.22 ±11.32 93.10 ±12.31
[Cu(L)Cl]·2H2O5 0 1 0 .49 ±9.31 76.19 ±10.31
[Cu(L)OAc]·2H2O5 0 1 1 .14 ±6.43 66.79 ±12.70
Ligand 50 3.56 ±9.28 59.48 ±5.68
Table 6: Eﬀect of drugs on the survival time in tumor-induced mice.
Group Dose (mg/kg) Median survival time (days) Mean survival time (days)
MST %T/C %ILS (Mean ± SEM) %T/C %ILS
Control — 18.00 — — 18.33 ±0.21 — —
Cisplatin 3.5 34.50 191.67 91.67 34.33 ±0.33a 187.28 87.28
[Cu(L)Cl]·2H2O 50 26.00 144.44 44.44 26.17 ±0.31a 142.77 42.77
[Cu(L)OAc]·2H2O 50 25.00 138.88 38.88 24.67 ±0.21a 134.59 34.59
Ligand 50 23.00 127.77 27.77 23.00 ±0.37a 125.48 25.48
aP<. 05 versus control groups, MST = Median Survival Time.
were carried out mainly with ﬁve diﬀerent concentrations of
the compounds. All the compounds were found to be cy-
totoxic and produced 50% cell death at or below a concen-
tration 19.1μg/ml. At 50μg/ml concentration, the standard
(cisplatin) showed 98% cell death. At 50μg/ml concentra-
tion, the [Cu(L)OAc]·2H2O, [Cu(L)Cl]·2H2O showed more
than 80% cell death. All the compounds were found to have
considerable cytotoxicity in the cell viability test.
5.7.3. AnticancerstudiesinEhrlichAscites
Carcinomamethod
Weightvariationparameter
The tumor inoculated control animals recorded signiﬁcant
weight gain by day-0. They gained a maximum weight of
19% by day-15. Cisplatin administration (on tenth postinoc-
ulation day) signiﬁcantly (P<. 05) reduced weight gain as
compared to control on day-15. The compounds also signif-
icantly (P<. 05) reduced the weight gain on day-15 as com-
pared to control (Table 4). Comparative eﬀects of treatments
versus cisplatin on reduction of body weights in tumor-
induced mice are given in Table 5.
Survivaltimeparameter
The eﬀect of compounds on survival of tumor-bearing mice
isshowninTable 6.Cisplatinsigniﬁcantlyprolongedtheme-
dian and mean survival times (P<. 05) with respect to
its control. It showed a signiﬁcant increase in the percent-
age lifespan of animals (ILS > 50). On the other hand, all
the compounds signiﬁcantly prolonged the mean survival
Times. The inﬂuence of all the compounds on %ILS was
more than 25%. By convention, a 25% increase in lifespan is
considered as possible anticancer activity of a test compound
[39].
Hematologicalparameters
The eﬀect of compounds on hematological parameters is
shown in Table 7. Tumor induction signiﬁcantly (P<. 05)
increased the total number of WBC by almost 4 times. Cis-
platin administration reversed this eﬀect signiﬁcantly (P<
.05). All the compounds signiﬁcantly (P<. 05) reversed
the tumor-induced rise in total counts of WBC. However,
they were not as eﬃcacious as cisplatin in reversing the
tumor-induced total counts. On diﬀerential counts, tumor-
induction caused a signiﬁcant reduction in lymphocyte and
a signiﬁcant (P<. 05) increase in neutrophil counts. This
was signiﬁcantly (P<. 05) reversed towards normal by cis-
platin and the test compounds. However, the compounds
were less eﬃcacious than cisplatin in their eﬀects. Tumor in-
duction caused signiﬁcant decrease in RBC and Hb almost
to the half of the normal animals [40]. This was signiﬁcantly
(P<. 05) reversed towards normal by cisplatin and the test
compounds.
5.8. Antimicrobialstudies
In the light of interesting antimicrobial activities of the co-
ordination complexes, the ligands and their corresponding
complexes were screened for antifungal and antibacterial ac-
tivity against Aspergillus niger, Candida albicans,a n dBacillus
cirroﬂagellosus, respectively, by the cup plate method using
Nutrient agar. The radial growth of the colony was recorded
on completion of the incubation and the mean diameter for
eachcomplexatasingleconcentrationwasrecorded.Theav-
eragepercentageinhibitionofthefungicidalgrowthmedium
comparedusingtheVincentequation[41]:I = 100(C−T)/C,
where I = percentage inhibition, T = average diameter of
the fungal and bacterial growth on the tested plates, and
C = average diameter of the growth on the control plates.
The screening data of the inhibition of the fungi and bac-
teria are given in Table 8. From the data, it is clear that theM. P. Sathisha et al. 9
Table 7: Eﬀect of the compounds on hematological parameters.
Group
Dose RBC Hb WBC Diﬀerential Leucocyte Count %
(mg/kg) (Mean ± SE) (Mean ± SE) (Mean ± SE)
(Millions/mm3)( g % )( 1 0 3cells/ mm3) Lymphocytes Neutrophils Monocytes
Normal — 5.03 ±0.28 15.72 ±0.32 8.59 ±0.16 86.23 ±0.61 13.03 ±0.46 1.07 ±0.33
Control — 2.14 ±0.34a,c 9.53 ±0.32a,c 32.31 ±0.67a,c 41.80 ± 0.39a,c 57.35 ±0.61a,c 1.25 ±0.43
Cisplatin 3.5 3.26 ±0.24a,b 13.08 ±0.29a,b 10.90 ±0.19a,b 77.97 ±0.48a,b 20.80 ±0.47b 1.22 ±0.54
[Cu(L)Cl]·2H2O5 0 3 .84 ±0.51a,b,c 11.71 ±0.29a,b,c 17.84 ±0.31a,b,c 68.97 ±0.20a,b,c 29.72 ±0.22a,b 1.32 ±0.31
[Cu(L)OAc]·2H2O5 0 4 .49 ±0.30a,b,c 12.79 ±0.17a,b,c 19.27 ±0.99a,b,c 68.10 ±0.45a,b,c 30.55 ±0.47a,b 1.35 ±0.43
Ligand 50 4.72 ±0.11a,b,c 11.92 ±0.15a,b,c 22.33 ±0.93a,b,c 62.78 ±0.27a,b,c 35.92 ±0.28a,b,c 1.30 ±0.63
aP<. 05 versus normal.
bP<. 05 versus control mice.
cP<. 05 versus cisplatin.
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Figure 3: Proposed structures of the complexes.
free ligand N, N
 -bis(isatin)thiocarbohydrazone is moder-
ately active against B. cirroﬂagellosus where as highly active
against fungi A. niger and C. albicans. On complexation,
thereisanotableenhancementofbothantibacterialaswellas
antifungal activity. The promising results were observed for
the Co(II) complex against both the fungi. The higher fungi
toxicity exhibited by the complexes may be ascribed to the
fact that the metal complexes are more susceptible to fungal
cells than bacterial cells.
6. CONCLUSION
Fromtheelementalanalysis,molarconductivity,UV-Visible,
magnetic,IRand 1HNMRspectraldataitwaspossibletode-
termine the type of coordination of the ligand in their metal
complexes. In all the complexes, only one part of the ligand
is coordinated to the metal ion resulting mononuclear com-
plexes. The ligand coordinates essentially through the car-
bonyl oxygen of the isatin fragment, the nitrogen atom of
the azomethine group and sulfur atom after deprotonation
to give ﬁve membered rings. The ligand acts as a monobasic,
tridentate (Figure 3).
The compounds showed considerable cytotoxic activity
in the trypan blue exclusion method. In the in vivo cancer
model (Ehrlich ascitic carcinoma model), the compounds
signiﬁcantly (P<. 05) reversed the tumor-induced changes
in the parameters monitored viz., percentage increase in
body weight, percentage increase in lifespan, tumor-viable
count, and hematological parameters (total and DLC of
WBC,totalRBC,andHemoglobincount).Theseeﬀectswere
almost comparable to cisplatin—the standard drug used in
the study. The compounds, however, were found to have
good eﬀect in prolonging the lifespan (ILS) as compared to
standard drug cisplatin. These ﬁndings imply that the com-
pounds might be having some anticancer principles.
Based on the data of the present study, it is very dif-
ﬁcult to suggest the possible mechanism of these com-
pounds for anticancer eﬀects. The compounds tested in our
present study have shown promising cytotoxic activity when
screenedusingtheinvitromethodandatthesametimewere10 Metal-Based Drugs
Table 8: Antimicrobial screening data of ligands and their com-
plexes.
Compound
Representation zone of inhibition
Antibacterial Antifungal
B.c A.n C.a
ligand + ++ ++
[Cu(L)Cl]·2H2O+ + + + + +
[Cu(L)OAc]·2H2O + ++ ++
[Ni(L)Cl] − +++ ++
[Ni(L)OAc] ++ ++ ++
[Co(L2)] ++ +++ +++
[Zn(L2)]·2H2O + ++ ++
Bacillus Cirroﬂagellosus = B.c.
Aspergillus niger = A.n.
Candida albican = C.a.
10mm = − (inactive).
10–20mm = +( w e a k l ya c t i v e ) .
21–25mm = ++ (moderatively active).
26–35mm = +++ (highly active).
36–40mm = ++++ (most active).
DMF = 12mm.
Norﬂoxacin = 29 P.a and 31 B.c;
Grisofulvin = 20 A.n and 23 C.a.
Index
(1) Concentration of the compound: 1mg/ml in dimethyl formamide.
(2) Quantity in each cup: 0.1ml.
(3) Diameter of the cup: 10mm.
(4) Control of the antibacterial activity: Norﬂoxaicn.
(5) Control of the antifungal activity: Grisofulvin.
(6) Solvent used: Dimethyl formamide.
showntohavegoodactivitywhentestedusingtheEhrlichas-
citescarcinomamodel.Thoughitisverydiﬃculttoconclude
anything at this stage, it can be assumed that after testing
against various other cancer models and at diﬀerent doses
these compounds may prove to be safer drugs for tomorrow.
Further, the promising results were observed for the
antimicrobial screening especially for the Co(II) complex
against both the fungi and what may be attributed to the fact
that the metal complexes are potentially active against fungal
cells than bacterial cells.
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